Znn3bq.jpeg
²é¿´: 1499  |  »Ø¸´: 3

»ªÎ÷ÎàÍ©Ê÷

Òø³æ (ÕýʽдÊÖ)

[½»Á÷] Å·ÖÞ ÂêÀö¾ÓÀアѧ½ð ÑÛ²¿¸øÒ©²©Ê¿¸ÚλÕÐÆ¸ ÒÑÓÐ3È˲ÎÓë

Fifteen Early Stage Researcher (ESR) vacancies in the Marie Sklodowska-Curie Innovative Training Network
http://www.uef.fi/web/ocuther-eu/vacancies

ÏêÇé¿ÉÒÔ×Ô¼ºÈ¥¿´ÁË¡£
Kinetic modelling of drugs and nanocarriers in the posterior eye segment; University of Eastern  

            Finland (Finland)

ESR2: Profiling of ADME properties of drug candidates and retinal cells models; University of Eastern

            Finland (Finland)

ESR3: Pathogenesis of age-related macular degeneration (AMD); University of Eastern Finland (Finland)

ESR4: Effects of sustained delivery of VCP inhibitors in animal models of retinitis pigmentosa; Eberhard-

            Karls-University, T¨¹bingen (Germany)

ESR5: Effects of intravitreal slow controlled release of neurotrophic retinal M¨¹ller glial cell (RMC)-derived

            factors; Eberhard-Karls-University, T¨¹bingen (Germany)

ESR6: Ocular response to Nanoparticles to be used for intraocular drug delivery; Queen¡¯s University Belfast

            (UK)

ESR7: Sustained intraocular drug delivery for the management of inflammation induced retinal

            angiogenesis; Queen¡¯s University Belfast (UK)

ESR8: Non-invasive pharmacological treatment of retinal degeneration in the Bardet-Biedl Syndrome and

            related ciliopathies (University of Strasbourg, France)

ESR9: Protein cages modified for cell selective delivery of siRNA to retinal cells; Eindhoven University of  

            Technology  (TU/e, The Netherlands)

ESR10: Supramolecular bioconjugates for ocular delivery; University of Padova (Italy)

ESR11: Multifunctional colloidal formulations for ocular delivery; University of Padova (Italy)

ESR12: Development of sustained release formulations for ocular delivery; Utrecht University (The

              Netherlands)

ESR13: Focused ultrasound (FUS) in ocular drug delivery; Utrecht University/University Medical Centre

              Utrecht Utrecht, The Netherlands)

ESR14: Magnetic Nanoparticles for Retinal Delivery; OZ Biosciences (OZB) (France)

ESR15: Development of a physiologically based systems pharmacology model of the eye; Simcyp (UK)
»Ø¸´´ËÂ¥
ÌìµÀ³êÇÚ
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

wzarlll

гæ (ÖøÃûдÊÖ)

2Â¥2017-01-04 18:07:55
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

ľéÈľ×Ó

ľ³æ (СÓÐÃûÆø)

¡ï
Сľ³æ: ½ð±Ò+0.5, ¸ø¸öºì°ü£¬Ð»Ð»»ØÌû
û˵ÔõôÉêÇë°¡£¬·½ÏòºÜºÏÊÊ
3Â¥2017-01-10 09:16:43
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

gnehzus924

ľ³æ (ÕýʽдÊÖ)

¡ï
Сľ³æ: ½ð±Ò+0.5, ¸ø¸öºì°ü£¬Ð»Ð»»ØÌû
Ç¡ºÃҪȥQueen¡¯s University Belfast£¬ ¶øÇÒµ¼Ê¦¸øµÄ¿ÎÌâ¾ÍÊǹØÓÚÑÛ²¿¸øÒ©¡£
ÇëÎÊÂ¥Ö÷Ò²ÊÇÕâ¸ö·½Ïòô£¿Èç¹ûÊǵϰ£¬Â¥Ö÷¿ÉÒÔÁô¸ö˽ÐÅÒ»ÏÂÁªÏµ·½Ê½Ã´£¿ÏÖÔÚÔÚдÑо¿¼Æ»®¡£
4Â¥2018-02-14 16:37:30
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû
Ïà¹Ø°æ¿éÌø×ª ÎÒÒª¶©ÔÄÂ¥Ö÷ »ªÎ÷ÎàÍ©Ê÷ µÄÖ÷Ìâ¸üÐÂ
×î¾ßÈËÆøÈÈÌûÍÆ¼ö [²é¿´È«²¿] ×÷Õß »Ø/¿´ ×îºó·¢±í
[¿¼ÑÐ] ±¾¿Æ211 ¹¤¿Æ085400 280·ÖÇóµ÷¼Á ¿É¿çרҵ +10 LZH£¨µÈ´ýµ÷¼ÁÖÐ 2026-04-10 10/500 2026-04-10 21:47 by fxue1114
[¿¼ÑÐ] Çóµ÷¼Á288 +6 ioodiiij 2026-04-10 8/400 2026-04-10 21:07 by zhouxiaoyu
[¿¼ÑÐ] 287Çóµ÷¼Á +15 Fnhc 2026-04-07 21/1050 2026-04-10 19:09 by chemisry
[¿¼ÑÐ] 22408 352·ÖÇóµ÷¼Á0854Àà +3 ŬÁ¦µÄÏÄÄ© 2026-04-09 3/150 2026-04-10 10:12 by 314126402
[¿¼ÑÐ] ²ÄÁÏר˶³õÊÔ·Ö332Ò»Ö¾Ô¸Î÷±±¹¤Òµ´óѧ£¬ +12 ¹ÊÈË?? 2026-04-09 12/600 2026-04-09 18:34 by Ccclqqq
[¿¼ÑÐ] 086000µ÷¼Á +4 Ê®Æßsa 2026-04-07 4/200 2026-04-09 09:27 by Ò¼ÍùŸoǰ
[¿¼ÑÐ] Çóµ÷¼Á +8 ³Ô¿Ú±ù¼¤Áè 2026-04-07 8/400 2026-04-09 08:03 by 5268321
[¿¼ÑÐ] 296Çóµ÷¼Á +3 Íô£¡£¿£¡ 2026-04-08 3/150 2026-04-08 22:00 by zhouyuwinner
[¿¼ÑÐ] 293·ÖÇóµ÷¼Á£¬ÍâÓïΪ¶íÓï +7 ¼ÓÒ»Ò»¾Å 2026-04-07 10/500 2026-04-08 20:14 by yutian743
[¿¼ÑÐ] 285Çóµ÷¼Á +7 ¶ñ·¨´ó¶þµÄÆøÎ¶ß 2026-04-05 10/500 2026-04-08 14:34 by zhq0425
[¿¼ÑÐ] Çóµ÷¼Á Ò»Ö¾Ô¸Î÷ÄϽ»Í¨´óѧ085701»·¾³¹¤³Ì 282·Ö +15 ¶à¶à°®³Ôºº±¤ 2026-04-04 16/800 2026-04-08 11:39 by i_cooler
[¿¼ÑÐ] 285Çóµ÷¼Á +5 mapmath 2026-04-06 6/300 2026-04-06 17:18 by À¶ÔÆË¼Óê
[¿¼ÑÐ] ²ÄÁϵ÷¼Á +14 Ò¼·¡·¡ÒÚ 2026-04-04 14/700 2026-04-05 23:31 by À´¿´Á÷ÐÇÓê10
[¿¼ÑÐ] 377Çóµ÷¼Á +6 by.ovo 2026-04-05 6/300 2026-04-05 22:18 by dongzh2009
[¿¼ÑÐ] 348Çóµ÷¼Á +3 ³µÀå×Ózzz 2026-04-05 3/150 2026-04-05 20:30 by à£à£à£0119
[¿¼ÑÐ] Ò»Ö¾Ô¸±±¾©½»Í¨´óѧ²ÄÁϹ¤³Ì×Ü·Ö358Çóµ÷¼Á +4 cs0106 2026-04-04 4/200 2026-04-05 18:46 by imissbao
[¿¼ÑÐ] 313Çóµ÷¼Á +5 º£ÈÕº£ÈÕ 2026-04-04 5/250 2026-04-05 15:52 by jndximd
[¿¼ÑÐ] 0854Çóµ÷¼Á +4 assdll 2026-04-04 4/200 2026-04-05 09:44 by zhq0425
[¿¼ÑÐ] Ò»Ö¾Ô¸»¦9£¬ÇóÉúÎïѧµ÷¼Á£¬326·Ö +6 Áõīī 2026-04-04 6/300 2026-04-04 19:44 by ÌÆãå¶ù
[¿¼ÑÐ] ²ÄÁÏ383Çóµ÷¼Á +5 ¹ùÑôÑôÑô³É 2026-04-04 5/250 2026-04-04 19:06 by dongzh2009
ÐÅÏ¢Ìáʾ
ÇëÌî´¦ÀíÒâ¼û